Isotopen Technologien München AG

https://www.itm-radiopharma.com

ITM, a privately held radiopharmaceutical biotech company founded in 2004, is dedicated to providing the most precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians and our partners through excellence in development, production and global supply. With patient benefit as the driving principle for all we do, ITM is advancing a broad pipeline combining its superior radioisotopes with targeting molecules to create precision oncology treatments. ITM is leveraging its leadership and nearly two decades of radioisotope expertise combined with its worldwide network to enable nuclear medicine to reach its full potential for helping patients live longer and better. *

	Start	2004-01-01 established
	End	2021-09-21 renamed
	Group	ITM (Group)
	Today	ITM Isotope Technologies Munich SE
	Successor	ITM Isotope Technologies Munich SE
	Industry	RADIOPHARMACEUTICAL (RPT)
	Person	Schuster, Steffen (ITM Isotopen Technologien München 201603 CEO)
	Person 2	Scharrer, Nicola (ITM Isotopen Technologien München 201603 Head of Marketing)

	Region	Garching
	Country	Germany
	Street	1 Lichtenbergstr.
	City	85748 Garching
	Tel	+49-89-329-8986-600
		Address record changed: 2021-06-16

Basic data	Employees	n. a.

		* Document for »About Section«: ITM Isotopen Technologien München AG. (5/4/21). "Press Release: ITM Establishes Subsidiary in Shanghai to Accelerate Introduction of Its Precision Oncology Portfolio in China".

		Record changed: 2023-12-30